233 related articles for article (PubMed ID: 10440436)
61. [Clinical experience with sulbactam/ampicillin in the pediatric field].
Sekiguchi T; Okamoto T; Ohara K; Kohzan S; Nishimori M; Miyazaki M
Jpn J Antibiot; 1989 Mar; 42(3):733-42. PubMed ID: 2746853
[TBL] [Abstract][Full Text] [Related]
62. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
Chan JC
Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
[TBL] [Abstract][Full Text] [Related]
63. A randomized, double-blind comparison of ampicillin/sulbactam and ceftriaxone in the prevention of surgical-site infections after neurosurgery.
Zhu XL; Wong WK; Yeung WM; Mo P; Tsang CS; Pang KH; Po YC; Aung TH
Clin Ther; 2001 Aug; 23(8):1281-91. PubMed ID: 11558864
[TBL] [Abstract][Full Text] [Related]
64. [Studies on sulbactam/ampicillin in the field of pediatrics].
Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
Jpn J Antibiot; 1989 Mar; 42(3):662-74. PubMed ID: 2664250
[TBL] [Abstract][Full Text] [Related]
65. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
Chambers HF; Kartalija M; Sande M
J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817
[TBL] [Abstract][Full Text] [Related]
66. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
Aronoff SC; Scoles PV; Makley JT; Jacobs MR; Blumer JL; Kalamchi A
Rev Infect Dis; 1986; 8 Suppl 5():S639-43. PubMed ID: 3026018
[TBL] [Abstract][Full Text] [Related]
67. Cefuroxime and ampicillin compared in a double-blind study in the treatment of lower respiratory tract infections.
Pines A; Raafat H; Khorasani M; Mullinger BM
Chemotherapy; 1981; 27(6):459-65. PubMed ID: 7028411
[TBL] [Abstract][Full Text] [Related]
68. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms.
Syriopoulou V; Bitsi M; Theodoridis C; Saroglou I; Krikos X; Tzanetou K
Rev Infect Dis; 1986; 8 Suppl 5():S630-3. PubMed ID: 3026016
[TBL] [Abstract][Full Text] [Related]
69. Pharmacokinetics of ampicillin and sulbactam in pediatric patients.
Nahata MC; Vashi VI; Swanson RN; Messig MA; Chung M
Antimicrob Agents Chemother; 1999 May; 43(5):1225-9. PubMed ID: 10223940
[TBL] [Abstract][Full Text] [Related]
70. Infectious complications after 809 biliary tract operations and results of a prospective randomized single-blind study comparing cefoxitin versus ampicillin plus an inhibitor of beta-lactamases.
Wittmann DH; Koltowski P; Oleszkiewicz J; Walker AP
Infection; 1990; 18(1):41-7. PubMed ID: 2179137
[TBL] [Abstract][Full Text] [Related]
71. [Clinical evaluation of sulbactam/ampicillin in children].
Ito S; Mayumi M; Ito M; Mikawa H
Jpn J Antibiot; 1989 Mar; 42(3):675-85. PubMed ID: 2664251
[TBL] [Abstract][Full Text] [Related]
72. Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days.
Kirton OC; O'Neill PA; Kestner M; Tortella BJ
J Trauma; 2000 Nov; 49(5):822-32. PubMed ID: 11086771
[TBL] [Abstract][Full Text] [Related]
73. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.
Betrosian AP; Douzinas EE
Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991
[TBL] [Abstract][Full Text] [Related]
74. [Clinical study on sulbactam/ampicillin in the pediatric field].
Takeda E; Hosoda T; Ichioka T; Miyao M
Jpn J Antibiot; 1989 Mar; 42(3):725-31. PubMed ID: 2746852
[TBL] [Abstract][Full Text] [Related]
75. [New specialty drugs registered in Austria. Unasyn].
Ganzinger U
Wien Klin Wochenschr; 1989 Nov; 101(21):754-60. PubMed ID: 2686180
[No Abstract] [Full Text] [Related]
76. An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.
Todisco T; Dal Farra F; Ciliberti G; Pirina P; Guelfi R; Serra G; Paris R; Mancuso I; Cepparulo M
J Chemother; 2008 Apr; 20(2):225-32. PubMed ID: 18467250
[TBL] [Abstract][Full Text] [Related]
77. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ
J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
[TBL] [Abstract][Full Text] [Related]
78. [Clinical results with sulbactam/ampicillin in a multicenter study of 425 patients].
Lode H; Springsklee M
Med Klin (Munich); 1989 May; 84(5):236-41. PubMed ID: 2661984
[TBL] [Abstract][Full Text] [Related]
79. Sulbactam/ampicillin in the treatment of lower respiratory infections.
Castellano MA
Drugs; 1988; 35 Suppl 7():53-6. PubMed ID: 3065054
[TBL] [Abstract][Full Text] [Related]
80. Perioperative systemic antibiotics for prophylaxis of infections in breast surgery: sulbactam/ampicillin versus mezlocillin/oxacillin.
Engel K; Wildfeuer A
Suppl Int J Gynecol Obstet; 1989; 2():29-34. PubMed ID: 2679681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
